|
|
||||||||
'-Chain Are Important for C2 Binding1
Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada
Previous work has indicated a role for the NH2-terminal
segment of the C3
'-chain in the binding interactions of C3b with a
number of its protein ligands. In particular, we have identified two
clusters of acidic residues, namely, E736 and E737 and to a lesser
extent D730 and E731, as being important in the binding of C3b to
factor B and complement receptor 1 and the binding of iC3b to
complement receptor 3. Whereas human C3 and C4 have an overall sequence
identity of 29%, over a segment near the NH2 termini of
their respective
'-chains the sequence identity is 56% (70%
chemical similarity). Given the functional similarity between the
C4b-C2 and C3b-B interactions in the respective formation of the
classical and alternative pathway C3 convertases, as well as the
sequence conservation of two acidic clusters, we hypothesized that
residues 744EED and 749DEDD within the
NH2-terminal segment of the C4
'-chain would mediate in
part the binding of C2 to C4b. We tested this hypothesis using three
independent approaches. Site-directed mutagenesis experiments revealed
that replacing subsets of the charged residues by their isosteric
amides within either acidic cluster resulted in molecules having
reduced C2 binding activity. Moreover, a synthetic peptide (C4 residues
740756) encompassing the two acidic clusters was a specific inhibitor
of the binding of C2 to red cell-associated C4b. Finally, Ab raised
against the above peptide was able to block the interaction between red
cell-associated C4b and fluid phase C2. Taken together, these results
strongly suggest that the NH2-terminal acidic residue-rich
segment of C4
'-chain contributes importantly to the interaction of
C4b with C2.
This article has been cited by other articles:
![]() |
V. N. Yadav, K. Pyaram, J. Mullick, and A. Sahu Identification of Hot Spots in the Variola Virus Complement Inhibitor (SPICE) for Human Complement Regulation J. Virol., April 1, 2008; 82(7): 3283 - 3294. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Singh, J. Mullick, J. Bernet, and A. Sahu Functional Characterization of the Complement Control Protein Homolog of Herpesvirus Saimiri: ARG-118 IS CRITICAL FOR FACTOR I COFACTOR ACTIVITIES J. Biol. Chem., August 11, 2006; 281(32): 23119 - 23128. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mullick, J. Bernet, Y. Panse, S. Hallihosur, A. K. Singh, and A. Sahu Identification of Complement Regulatory Domains in Vaccinia Virus Complement Control Protein J. Virol., October 1, 2005; 79(19): 12382 - 12393. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mutsuro, N. Tanaka, Y. Kato, A. W. Dodds, T. Yano, and M. Nakao Two Divergent Isotypes of the Fourth Complement Component from a Bony Fish, the Common Carp (Cyprinus carpio) J. Immunol., October 1, 2005; 175(7): 4508 - 4517. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mullick, A. K. Singh, Y. Panse, V. Yadav, J. Bernet, and A. Sahu Identification of Functional Domains in Kaposica, the Complement Control Protein Homolog of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) J. Virol., May 1, 2005; 79(9): 5850 - 5856. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Inal and J. A. Schifferli Complement C2 Receptor Inhibitor Trispanning and the {beta}-Chain of C4 Share a Binding Site for Complement C2 J. Immunol., May 15, 2002; 168(10): 5213 - 5221. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |